APA (7th ed.) Citation

Duboscq, C., Martinuzzo, M. E., Ceresetto, J., Lopez, M., Barrera, L., Oyhamburu, J., & Stemmelin, G. (2018). The fibrinogen prothrombin time‐derived method is not useful in patients anticoagulated with low molecular weight heparins or rivaroxaban. Journal of thrombosis and haemostasis, 16(8), 1626-1631. https://doi.org/10.1111/jth.14158

Chicago Style (17th ed.) Citation

Duboscq, C., M. E. Martinuzzo, J. Ceresetto, M. Lopez, L. Barrera, J. Oyhamburu, and G. Stemmelin. "The Fibrinogen Prothrombin Time‐derived Method Is Not Useful in Patients Anticoagulated with Low Molecular Weight Heparins or Rivaroxaban." Journal of Thrombosis and Haemostasis 16, no. 8 (2018): 1626-1631. https://doi.org/10.1111/jth.14158.

MLA (9th ed.) Citation

Duboscq, C., et al. "The Fibrinogen Prothrombin Time‐derived Method Is Not Useful in Patients Anticoagulated with Low Molecular Weight Heparins or Rivaroxaban." Journal of Thrombosis and Haemostasis, vol. 16, no. 8, 2018, pp. 1626-1631, https://doi.org/10.1111/jth.14158.